Biotech Values

[Rocky3]

Numbers for scripts, including original info:

Week Lov. m-en

7/9 51,269

7/16 54,721

7/23 54,237

7/30 52,702 1,702

8/6 42,721 11,865

8/13 38,500 16,028

8/20 36,016 18,719

8/27 33,208 20,890

9/3 32,863 22,132

9/10 30,021 21,437

9/17 31,104 24,377

9/24 31,289 25,271

10/01 30,631 25,887

10/08 31,179 25,803

10/15 30,066 26,278

10/22 30,362 26,809

10/29 29,753 27,284

11/05 29,456 27,369

11/12 28,568 28,337

11/19 28,101 28,998

11/26 26,202 26,618

12/3 26,393 28,983

12/10 27,037 30,355

12/17 26,059 30,640

12/24 25,864 30,044

12/31 23,480 26,639

1/7 24,002 28,768

1/14 25,301 31,571

1/21 25,538 31,724

1/28 26,276 32,433

NOTE: For the first time the analyst who provided the numbers commented that TEVA has a generic near approval that will take the majority of the generic market (FWIW).